Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3a,Condition 3b 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000543,serum glucose level,,,,375.705,mg/dl,12.5965,30.855,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70240,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000543,serum glucose level,,,,252.285,mg/dl,28.1569,68.97,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70241,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000358,serum insulin level,,,,0.116,mg/dl,0.0047,0.0116,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70278,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000358,serum insulin level,,,,0.0783,mg/dl,0.0166,0.0406,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70279,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",epididymal fat pad mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000658,epididymal fat pad weight to body weight ratio,fat pad weight/100g body weight,,,2.17,%,0.0816,0.2,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70232,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",epididymal fat pad mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000658,epididymal fat pad weight to body weight ratio,fat pad weight/100g body weight,,,0.78,%,0.0408,0.1,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70233,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood triglyceride amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000360,serum triglyceride level,,,,2412.40096,mg/dl,173.416,424.7808,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70219,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood triglyceride amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000360,serum triglyceride level,,,,46.90288,mg/dl,3.6128,8.8496,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70220,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,98 days,4,,CMO:0000004,systolic blood pressure,,,,141,mmHg,8.0,16.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days) then adrenalectomy then controlled sodium content diet (0.3 %) (for 28 days) and dexamethasone (20 ug/d) ,69688,controlled sodium content diet (8 %) (for 28 days),adrenalectomy,controlled sodium content diet (0.3 %) (for 28 days),dexamethasone (20 ug/d) 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",total urine protein amount,,RS:0003328,SS/NEisSlc,male,98 days,4,,CMO:0000756,urine total protein excretion rate,,,,35,mg/d,3.0,6.0,MMO:0000335,urine total protein analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days) then adrenalectomy then controlled sodium content diet (0.3 %) (for 28 days) and dexamethasone (20 ug/d) ,69690,controlled sodium content diet (8 %) (for 28 days),adrenalectomy,controlled sodium content diet (0.3 %) (for 28 days),dexamethasone (20 ug/d) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood free fatty acid amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000547,serum free fatty acids level,,,,4.13,mmol/l,0.1225,0.3,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70234,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood free fatty acid amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000547,serum free fatty acids level,,,,1.4,mmol/l,0.0816,0.2,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70235,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,57081.817611,(mg/dl) x min,512.9083,1256.3636,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70272,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,42156.3632148,(mg/dl) x min,1723.55,4221.8181,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70273,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000012,body weight,,,,352.9,g,1.5513,3.8,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70211,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000012,body weight,,,,257.6,g,10.2879,25.2,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70212,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood uric acid amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0002041,serum uric acid level,,,,67.2,umol/l,2.5311,6.2,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70284,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood uric acid amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0002041,serum uric acid level,,,,107.3,umol/l,3.1843,7.8,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70285,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",kidney mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000622,single kidney wet weight to body weight ratio,,,,3.8,g/kg,0.0408,0.1,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70286,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",kidney mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000622,single kidney wet weight to body weight ratio,,,,3,g/kg,0.0408,0.1,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70287,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",heart mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000074,heart weight to body weight ratio,,,,3.4,g/kg,0.4082,1.0,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70209,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",heart mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000074,heart weight to body weight ratio,,,,3.6,g/kg,0.0408,0.1,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70210,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",liver mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000633,liver weight to body weight ratio,,,,41.7,g/kg,0.8165,2.0,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70217,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",liver mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000633,liver weight to body weight ratio,,,,35.7,g/kg,1.633,4.0,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70218,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),,